A Joint Working case study between Gloucester Clinical Commissioning Group (CCG) and Teva UK Limited
This is a case study of how Gloucestershire CCG worked in a local joint working initiative with the Project Group from Teva UK Limited to improve asthma outcomes in relevant practices.
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are long term conditions that feature prominently in Domain 2 of the NHS Outcomes Framework 2013/2014 and National COPD and Asthma Outcomes Strategy, Department of Health.
Locally in 2011, NHS Gloucestershire - now Gloucestershire Clinical Commissioning Group (CCG) - saw an increase in number of hospital admissions per patient and number of patients admitted for asthma ICD-10 codes.
The CCG project lead approached Teva UK Limited to determine if they would be interested in working collaboratively on rolling out the Advance Inhaler Training module that had been recently accredited by the WCCPE at Cardiff University, as it focuses on the importance of inhaler technique which they believed was vital in order to gain control of the increase in admissions related to asthma.
Gloucestershire then had around 41,000 diagnosed patients with asthma and around 10,000 diagnosed with COPD, spending approximately £14m annually on respiratory care. However, it was recognised that:
Gloucestershire CCG believed that having a number of accredited AIT trainers locally would have a positive effect on the integrated approach that they are aiming to achieve.
Through the formation of an asthma project group, there was a desire to run an AIT course to train 14 healthcare professionals (HCPs) from Gloucestershire CCG. These were made up of practice support pharmacists (PSPs) and practice nurses that had an interest in respiratory, along with secondary care respiratory pharmacists that had an interest in asthma.
Once the relevant HCPs had been trained and accredited via WCCPE, they were tasked with up-skilling other HCPs from the 86 practices, 113 community pharmacies and also the hospitals within Gloucestershire CCG.
The project aimed to improve respiratory care by raising the importance of device technique in a consistent and informed way with healthcare professionals and patients.
Recognising this opportunity, the objectives of this joint working initiative in Gloucestershire CCG was to:
Joint Working Initiative with Teva UK Limited
In order to achieve these outcomes, Gloucestershire CCG worked in collaboration with
Teva UK Limited as they provided:
Both Gloucestershire CCG and Teva UK Limited abided by the relevant regulatory bodies and guidance, including the ABPI Code of Practice and guidance.
The project was split into three distinct phases.
The project succeeded in improving respiratory care by raising the importance of device technique in a consistent and informed way with healthcare professionals and patients.
(a) Over 900 healthcare professionals received Advanced Inhaler Training and consistent training around device technique
(b) Positive feedback was received from healthcare professionals of the Advanced Inhaler Training
Feedback was received from patients who participated
(c) Impact on hospital admissions and associated costs
This project demonstrated a successful collaborative approach to address a significant issue facing the local health economy. Factors beyond the scope of this project may have impacted on the project results achieved.
The project improved respiratory care by raising the importance of device technique in a consistent and informed way with healthcare professionals and patients.
Joint working between Teva UK Limited and the NHS must be for the benefit of patients or the NHS and preserve patient care.4